World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
35315
World Ranking
9265
National Ranking
4783

Allan J. Pantuck publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Allan J. Pantuck sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 558 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Allan J. Pantuck D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Allan J. Pantuck sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Allan J. Pantuck is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on medicine, biochemistry, genetics, and molecular biology, with significant contributions to pulmonary and respiratory medicine, molecular biology, oncology, surgery, and cancer research.

The scientist's work covers several main topics including:

  • Renal cell carcinoma treatment
  • Prostate cancer diagnosis and treatment
  • Renal and related cancers
  • Prostate cancer treatment and research
  • Bladder and urothelial cancer treatments
  • Cancer genomics and diagnostics
  • Cancer immunotherapy and biomarkers

Frequent publication venues where Allan J. Pantuck has contributed include:

  • The Journal of Urology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Urologic Oncology Seminars and Original Investigations
  • The Lancet Oncology

Notable recent papers authored or coauthored by Allan J. Pantuck include:

  • A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer, 2020, Clinical Cancer Research
  • Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer, 2020, The Journal of Urology
  • MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study, 2022, The Lancet Oncology
  • [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial, 2024, The Lancet Oncology
  • The Potential Revolution of Cancer Treatment with CRISPR Technology, 2023, Cancers

Allan J. Pantuck collaborates frequently with several coauthors, including:

  • Brian Shuch
  • Alexandra Drakaki
  • Laurence Klotz
  • Christian P. Pavlovich
  • Gencay Hatiboglu

Best Publications

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA

    Allan J. Pantuck;Amnon Zisman;Arie S. Belldegrun

  • Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System

    Amnon Zisman;Allan J. Pantuck;Fredrick Dorey;Jonathan W. Said

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    Jean Jacques Patard;Emmanuelle Leray;Nathalie Rioux-Leclercq;Luca Cindolo

  • Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma

    Amnon Zisman;Allan J. Pantuck;Jeffery Wieder;Debby H. Chao

  • Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy

    Matthew H.T. Bui;David Seligson;Ken ryu Han;Allan J. Pantuck

  • SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE

    Jean-Jacques Patard;Oleg Shvarts;John S. Lam;Allan J. Pantuck

  • Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

    Alain Ravaud;Robert J. Motzer;Hardev S. Pandha;Daniel J. George

  • Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma

    Matthew H. T. Bui;David Seligson;Ken-ryu Han;Allan J. Pantuck

  • Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer

    Allan J. Pantuck;John T. Leppert;Nazy Zomorodian;William Aronson

  • Gene Signatures of Progression and Metastasis in Renal Cell Cancer

    Jon Jones;Hasan Otu;Dimitrios Spentzos;Shakirahmed Kolia

  • Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

    Jean Jacques Patard;Hyung L. Kim;John S. Lam;Frederick J. Dorey

  • Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.

    Allan J. Pantuck;David B. Seligson;Tobias Klatte;Hong Yu

  • Pomegranate Ellagitannin-Derived Metabolites Inhibit Prostate Cancer Growth and Localize to the Mouse Prostate Gland

    Navindra P. Seeram;William J. Aronson;Yanjun Zhang;Susanne M. Henning

  • Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.

    Allan J. Pantuck;Amnon Zisman;Fredrick Dorey;Debby H. Chao

  • Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review

    Maxine Sun;Shahrokh F. Shariat;Christopher Cheng;Vincenzo Ficarra

  • Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.

    Jonathan R. Young;Daniel Margolis;Steven Sauk;Allan J. Pantuck

  • Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

    Karim Bensalah;Allan J. Pantuck;Nathalie Rioux-Leclercq;Rodolphe Thuret

  • POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM

    John S. Lam;Oleg Shvarts;John T. Leppert;Allan J. Pantuck

  • Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    J.-J. Patard;E. Leray;N. Rioux-Leclercq;L. Cindolo

Frequent Co-Authors

Arie S. Belldegrun
Arie S. Belldegrun University of California, Los Angeles
Robert A. Figlin
Robert A. Figlin Cedars-Sinai Medical Center
Jonathan W. Said
Jonathan W. Said University of California, Los Angeles
Alexandre de la Taille
Alexandre de la Taille Université Paris Cité
Daniel J. George
Daniel J. George Duke University
Laurent Salomon
Laurent Salomon Necker-Enfants Malades Hospital
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Alain Ravaud
Alain Ravaud University of Bordeaux
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
David Heber
David Heber University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine offers a wide range of alternative and complementary paths beyond MD or DO programs. Many students build foundational experience by studying through medical billing and coding schools with financial aid, providing quick entry into the healthcare administration field.

For those interested in patient care, nursing schools that don't require teas test create more accessible options to start a nursing degree, eliminating common exam-related barriers. Leadership roles within healthcare also continue to grow. Pursuing a healthcare administration degree can prepare you for administrative and managerial positions in various medical settings.

Additionally, nurses seeking further advancement may consider asn to np bridge programs that enable registered nurses to earn advanced degrees efficiently. These diverse pathways offer robust job prospects in healthcare, allowing for flexibility, career growth, and hands-on impact even if you do not pursue a traditional medical doctor degree.

Best Scientists Citing Allan J. Pantuck

Trending Scientists

Recently Published Articles